Titelia

Holdings of KVP Capital Advisors, LP

30 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 63.2 % of the equity sleeve

Sector breakdown

  • Health care 5.8 %
  • Unattributed 94.2 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 100.0 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US30129.4M $100.00 %

Positions

RankCompanySharesValueWeight
1Terns Pharmaceuticals Inc 440,00023.2M $
2Praxis Precision Medicines Inc 42,90013.8M $
3Aadi Bioscience Inc 2,165,9977.5M $
4Axsome Therapeutics Inc 36,2006.1M $
5Sutro Biopharma Inc 226,5755.6M $
6Protagonist Therapeutics Inc 53,0005.6M $
7Erasca Inc 340,0005.5M $
8Trevi Therapeutics Inc 414,0004.9M $
9Tango Therapeutics Inc 230,2644.8M $
10Insmed Inc 28,4974.7M $
11Edgewise Therapeutics Inc 133,0004.2M $
12Revolution Medicines Inc 40,2003.9M $
13Disc Medicine Inc 58,2503.7M $
14MBX Biosciences Inc 121,5243.6M $
15Savara Inc 605,2803.3M $
16United Therapeutics Corp 4,7502.8M $
17Travere Therapeutics Inc 91,0002.7M $
18Ideaya Biosciences Inc 79,7002.7M $
19Compass Therapeutics Inc 500,0002.6M $
20Ocular Therapeutix Inc 300,0002.5M $
21Viridian Therapeutics Inc 125,0002.4M $
22Scholar Rock Holding Corp 45,0002.2M $
23Immix Biopharma Inc 230,4232.1M $
24Soleno Therapeutics Inc 59,7002M $
25Nektar Therapeutics 26,9001.9M $
26Cabaletta Bio Inc 505,4311.4M $
27ACHIEVE LIFE SCIENCES INC 462,3551.4M $
28Vera Therapeutics Inc 32,7001.3M $
29Celcuity Inc 4,000456.6K $
30VYNE THERAPEUTICS INC 500,551299.1K $